000 01273 a2200373 4500
005 20250512212607.0
264 0 _c19850606
008 198506s 0 0 eng d
022 _a0251-1649
040 _aNLM
_beng
_cNLM
100 1 _aMolin, L
245 0 0 _aFirst observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology research
_c1984
300 _a445-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPeptide Fragments
_xadministration & dosage
650 0 4 _aThymopentin
650 0 4 _aThymopoietins
_xadministration & dosage
650 0 4 _aThymus Hormones
_xadministration & dosage
650 0 4 _aTime Factors
700 1 _aSchmid, F
700 1 _aBolla, K
773 0 _tInternational journal of clinical pharmacology research
_gvol. 4
_gno. 6
_gp. 445-9
999 _c6398210
_d6398210